153 related articles for article (PubMed ID: 23192155)
1. Increased urinary CCL2: Cr ratio at 6 months is associated with late renal allograft loss.
Ho J; Wiebe C; Rush DN; Rigatto C; Storsley L; Karpinski M; Gao A; Gibson IW; Nickerson PW
Transplantation; 2013 Feb; 95(4):595-602. PubMed ID: 23192155
[TBL] [Abstract][Full Text] [Related]
2. Elevated urinary CCL2: Cr at 6 months is associated with renal allograft interstitial fibrosis and inflammation at 24 months.
Ho J; Wiebe C; Gibson IW; Hombach-Klonisch S; Gao A; Rigatto C; Karpinski M; Storsley L; Nickerson PW; Rush DN
Transplantation; 2014 Jul; 98(1):39-46. PubMed ID: 24646773
[TBL] [Abstract][Full Text] [Related]
3. Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome.
Hirt-Minkowski P; Rush DN; Gao A; Hopfer H; Wiebe C; Nickerson PW; Schaub S; Ho J
Transplantation; 2016 Sep; 100(9):1988-96. PubMed ID: 27548845
[TBL] [Abstract][Full Text] [Related]
4. Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts.
Ho J; Rush DN; Gibson IW; Karpinski M; Storsley L; Bestland J; Stefura W; HayGlass KT; Nickerson PW
Transplantation; 2010 Aug; 90(4):394-400. PubMed ID: 20625355
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
[TBL] [Abstract][Full Text] [Related]
6. Advantages of kidney transplant precocity in graft long-term survival.
Malho A; Malheiro J; Fonseca I; Martins LS; Pedroso S; Almeida M; Dias L; Castro Henriques A; Cabrita A
Transplant Proc; 2012 Oct; 44(8):2344-7. PubMed ID: 23026589
[TBL] [Abstract][Full Text] [Related]
7. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
[TBL] [Abstract][Full Text] [Related]
8. Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients.
Oterdoom LH; van Ree RM; de Vries AP; Gansevoort RT; Schouten JP; van Son WJ; Homan van der Heide JJ; Navis G; de Jong PE; Gans RO; Bakker SJ
Transplantation; 2008 Aug; 86(3):391-8. PubMed ID: 18698241
[TBL] [Abstract][Full Text] [Related]
9. Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses.
Valderhaug TG; Hjelmesæth J; Jenssen T; Røislien J; Leivestad T; Hartmann A
Transplantation; 2012 Oct; 94(7):714-20. PubMed ID: 22965263
[TBL] [Abstract][Full Text] [Related]
10. Pretransplant serum phosphate levels and outcomes after kidney transplantation.
Sapir-Pichhadze R; Parmar K; Kim SJ
J Nephrol; 2012; 25(6):1091-7. PubMed ID: 22383343
[TBL] [Abstract][Full Text] [Related]
11. Donor-recipient age difference and graft survival in living donor kidney transplantation.
Lee YJ; Chang JH; Choi HN; Jung JY; Kim YS; Chung WK; Park YH; Lee HH
Transplant Proc; 2012 Jan; 44(1):270-2. PubMed ID: 22310630
[TBL] [Abstract][Full Text] [Related]
12. Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation.
Blydt-Hansen TD; Gibson IW; Gao A; Dufault B; Ho J
Transplantation; 2015 Apr; 99(4):797-804. PubMed ID: 25222013
[TBL] [Abstract][Full Text] [Related]
13. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection.
Prodjosudjadi W; Daha MR; Gerritsma JS; Florijn KW; Barendregt JN; Bruijn JA; van der Woude FJ; van Es LA
Nephrol Dial Transplant; 1996 Jun; 11(6):1096-103. PubMed ID: 8671975
[TBL] [Abstract][Full Text] [Related]
14. Increased recipient body mass index is associated with acute rejection and other adverse outcomes after kidney transplantation.
Curran SP; Famure O; Li Y; Kim SJ
Transplantation; 2014 Jan; 97(1):64-70. PubMed ID: 24056619
[TBL] [Abstract][Full Text] [Related]
15. Very early serum creatinine as a surrogate marker for graft survival beyond 10 years.
Pascual J; Marcén R; Zamora J; Fernández AM; Burgos FJ; Villafruela JJ; Ortuño J
J Nephrol; 2009; 22(1):90-8. PubMed ID: 19229823
[TBL] [Abstract][Full Text] [Related]
16. Urinary biomarkers of renal transplant outcome.
Ho J; Rush DN; Nickerson PW
Curr Opin Organ Transplant; 2015 Aug; 20(4):476-81. PubMed ID: 26107968
[TBL] [Abstract][Full Text] [Related]
17. The independent association between serum uric acid and graft outcomes after kidney transplantation.
Haririan A; Nogueira JM; Zandi-Nejad K; Aiyer R; Hurley H; Cooper M; Klassen DK; Weir MR
Transplantation; 2010 Mar; 89(5):573-9. PubMed ID: 19997058
[TBL] [Abstract][Full Text] [Related]
18. Harmful effects of viral replication in seropositive hepatitis C virus renal transplant recipients.
Gentil Govantes MA; Esforzado N; Cruzado JM; González-Roncero FM; Balaña M; Saval N; Morales JM
Transplantation; 2012 Dec; 94(11):1131-7. PubMed ID: 23104249
[TBL] [Abstract][Full Text] [Related]
19. Delayed graft function after renal transplantation: an unresolved problem.
Gavela Martínez E; Pallardó Mateu LM; Sancho Calabuig A; Beltrán Catalán S; Kanter Berga J; Ávila Bernabeu AI; Crespo Albiach J
Transplant Proc; 2011; 43(6):2171-3. PubMed ID: 21839224
[TBL] [Abstract][Full Text] [Related]
20. Transplantation with kidneys retrieved from deceased donors with acute renal failure.
Klein R; Galante NZ; de Sandes-Freitas TV; de Franco MF; Tedesco-Silva H; Medina-Pestana JO
Transplantation; 2013 Feb; 95(4):611-6. PubMed ID: 23274968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
